Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about APOPTOSIS: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Apoptosis is programmed cell death essential for normal development and tissue homeostasis. In neurodegeneration, aberrant activation of apoptotic pathways contributes to neuronal loss. Key mediators include caspases, Bcl-2 family proteins, cytochrome c, and death receptors. Both intrinsic (mitochondrial) and extrinsic (death receptor) pathways are implicated in diseases like Alzheimer's, Parkinson's, and ALS.
No AI portrait yet
Knowledge base pages for this entity
graph TD
subgraph Pathology["Pathology"]
APOPTOSIS["APOPTOSIS"] -->|"causes"| NEURODEGENERATION["NEURODEGENERATION"]
APOPTOSIS["APOPTOSIS"] -->|"associated with"| NLRP3["NLRP3"]
APOPTOSIS["APOPTOSIS"] -->|"associated with"| MICROGLIA["MICROGLIA"]
APOPTOSIS["APOPTOSIS"] -->|"associated with"| NEURON["NEURON"]
APOPTOSIS["APOPTOSIS"] -->|"associated with"| APP["APP"]
APOPTOSIS["APOPTOSIS"] -->|"associated with"| GFAP["GFAP"]
BECN1["BECN1"] -->|"associated with"| APOPTOSIS["APOPTOSIS"]
AMYLOID["AMYLOID"] -->|"associated with"| APOPTOSIS["APOPTOSIS"]
end
subgraph Signaling["Signaling"]
APOPTOSIS["APOPTOSIS"] -.->|"inhibits"| CANCER["CANCER"]
APOPTOSIS["APOPTOSIS"] -->|"activates"| Lymphoma["Lymphoma"]
APOPTOSIS["APOPTOSIS"] -->|"activates"| Apoptosis["Apoptosis"]
MITOPHAGY["MITOPHAGY"] -->|"activates"| APOPTOSIS["APOPTOSIS"]
AUTOPHAGY["AUTOPHAGY"] -->|"regulates"| APOPTOSIS["APOPTOSIS"]
AKT["AKT"] -.->|"inhibits"| APOPTOSIS["APOPTOSIS"]
INFLAMMATION["INFLAMMATION"] -->|"activates"| APOPTOSIS["APOPTOSIS"]
end
style APOPTOSIS fill:#5d4400,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
style NEURODEGENERATION fill:#5d4400,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style CANCER fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style NLRP3 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style MICROGLIA fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style NEURON fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style APP fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style GFAP fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Lymphoma fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Apoptosis fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style BECN1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style AMYLOID fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style MITOPHAGY fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style AUTOPHAGY fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style AKT fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style INFLAMMATION fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Ischemia | activates | disease | 1.00 |
| Mitochondrial Function | activates | pathway | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| Inflammation | activates | disease | 1.00 |
| Mapk | activates | pathway | 1.00 |
| Apoptosis | activates | pathway | 1.00 |
| Gastric Cancer | activates | disease | 1.00 |
| PI3K | associated_with | gene | 1.00 |
| Tumor | inhibits | disease | 1.00 |
| Mtor | therapeutic_target | pathway | 1.00 |
| Mtor | activates | pathway | 1.00 |
| BCL2 | associated_with | gene | 1.00 |
| ALZHEIMER | associated_with | gene | 1.00 |
| Lymphoma | activates | disease | 1.00 |
| DEMENTIA | associated_with | gene | 1.00 |
| MYC | activates | gene | 1.00 |
| Drug Resistance | activates | pathway | 1.00 |
| Stem Cell | activates | pathway | 1.00 |
| TP53 | associated_with | gene | 1.00 |
| Cancer | activates | disease | 1.00 |
| Colorectal Cancer | inhibits | disease | 1.00 |
| Als | causes | disease | 1.00 |
| Diabetes | associated_with | disease | 1.00 |
| Alzheimer | associated_with | disease | 1.00 |
| GENES | therapeutic_target | gene | 1.00 |
| Lung Cancer | therapeutic_target | disease | 1.00 |
| P53 | inhibits | gene | 1.00 |
| AUTOPHAGY | targets | gene | 1.00 |
| ds-db4a006ea647 | provides_data_for | dataset | 1.00 |
| NEURODEGENERATION | causes | phenotype | 1.00 |
| NF-ΚB | inhibits | gene | 1.00 |
| Osteoarthritis | therapeutic_target | disease | 1.00 |
| DNA | inhibits | gene | 1.00 |
| Cancer | treats | disease | 1.00 |
| Breast Cancer | treats | disease | 1.00 |
| NEURODEGENERATIVE DISEASES | therapeutic_target | gene | 1.00 |
| ASTROCYTES | associated_with | gene | 1.00 |
| P53 | therapeutic_target | gene | 1.00 |
| Microrna | therapeutic_target | pathway | 1.00 |
| Tumor | treats | disease | 1.00 |
| Invasion | regulates | pathway | 1.00 |
| Aging | activates | disease | 1.00 |
| Blood-Brain Barrier | therapeutic_target | pathway | 1.00 |
| NF-ΚB | therapeutic_target | gene | 1.00 |
| BCL2 | therapeutic_target | gene | 1.00 |
| NF-KB | associated_with | gene | 1.00 |
| Breast Cancer | activates | disease | 1.00 |
| Differentiation | activates | pathway | 1.00 |
| Cardiac | therapeutic_target | disease | 1.00 |
| Mapk | therapeutic_target | pathway | 1.00 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ERK | activates | gene | 1.00 |
| EGFR | activates | gene | 1.00 |
| BCL-2 | regulates | gene | 1.00 |
| Stroke | inhibits | disease | 1.00 |
| DNA | activates | gene | 1.00 |
| NRF2 | regulates | gene | 1.00 |
| Cancer | inhibits | disease | 1.00 |
| P53 | regulates | gene | 1.00 |
| Als | expressed_in | disease | 1.00 |
| Neurodegeneration | therapeutic_target | disease | 1.00 |
| C-JUN | activates | gene | 1.00 |
| TNF | activates | gene | 1.00 |
| MTOR | activates | gene | 1.00 |
| Tumor | inhibits | disease | 1.00 |
| Inflammation | therapeutic_target | disease | 1.00 |
| Alzheimer | activates | disease | 1.00 |
| Neurodegeneration | activates | disease | 1.00 |
| Cardiac | therapeutic_target | disease | 1.00 |
| NEURODEGENERATION | associated_with | gene | 1.00 |
| PI3K | activates | gene | 1.00 |
| AKT | activates | gene | 1.00 |
| GENES | associated_with | gene | 1.00 |
| PI3K | inhibits | gene | 1.00 |
| PTEN | activates | gene | 1.00 |
| AKT | associated_with | gene | 1.00 |
| CANCER | treats | gene | 1.00 |
| Lung Cancer | therapeutic_target | disease | 1.00 |
| MTOR | regulates | gene | 1.00 |
| NRF2 | activates | gene | 1.00 |
| Cancer | treats | disease | 1.00 |
| Breast Cancer | treats | disease | 1.00 |
| Osteoarthritis | therapeutic_target | disease | 1.00 |
| DNA | inhibits | gene | 1.00 |
| MIRNAS | activates | gene | 1.00 |
| BCL-2 | activates | gene | 1.00 |
| Tumor | treats | disease | 1.00 |
| STROKE | therapeutic_target | gene | 1.00 |
| Parkinson | therapeutic_target | disease | 1.00 |
| Breast Cancer | activates | disease | 1.00 |
| Cardiac | regulates | disease | 1.00 |
| Cardiovascular | activates | disease | 1.00 |
| APOPTOSIS | associated_with | gene | 1.00 |
| BCL2 | inhibits | gene | 1.00 |
| Neurodegeneration | associated_with | disease | 1.00 |
| ds-db4a006ea647 | data_in | dataset | 1.00 |
| Senescence | activates | disease | 1.00 |
| Diabetes | associated_with | disease | 1.00 |
| BAX | regulates | gene | 1.00 |
| TNF | therapeutic_target | gene | 1.00 |
| MYC | activates | gene | 1.00 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| ATM Kinase Hyperactivation Triggers DNA Damage Response Over | 0.837 | ALS | View |
| Apoptosis-Senescence Decision Point Intervention | 0.649 | - | Senescent cell clearance as neurodegener |
| Colonic Th17/IL-17A Axis → Peripheral Immune Recruitment to | 0.640 | neurodegeneration | What are the mechanisms by which gut mic |
| TREM2-Apoptosis Axis for Cellular Clearance | 0.000 | - | TREM2 Therapeutic Strategy Post-INVOKE-2 |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-25 | 5 hypotheses Top: 0.530
neurodegeneration | 2026-04-10 | 0 hypotheses
molecular biology | 2026-04-09 | 7 hypotheses Top: 0.455
neurodegeneration | 2026-04-08 | 2 hypotheses Top: 0.580
neurodegeneration | 2026-04-07 | 7 hypotheses Top: 0.690
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| dilncRNA-mediated molecular crowding and phase separation | exploratory | 0.900 | 0.00 | cultured cells | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Metformin and its potential influence on cell fate decision between apoptosis an [PMID:39267853] | ["Hajimohammadebrahim-Ketabforoush M", " | Front Oncol | 2024 | 0 |
Multi-agent debates referencing this entity
closed · Rounds: 6 · Score: 0.95 · 2026-04-27
closed · Rounds: 4 · Score: 0.50 · 2026-04-27
closed · Rounds: 4 · Score: 0.40 · 2026-04-27
closed · Rounds: 4 · Score: 0.40 · 2026-04-27
closed · Rounds: 4 · Score: 0.54 · 2026-04-25
closed · Rounds: 4 · Score: 0.61 · 2026-04-21
closed · Rounds: 4 · Score: 0.66 · 2026-04-21
closed · Rounds: 4 · Score: 0.50 · 2026-04-20
closed · Rounds: 5 · Score: 0.93 · 2026-04-11
closed · Rounds: 4 · Score: 0.95 · 2026-04-10
Hypotheses and analyses mentioning APOPTOSIS in their description or question text
No additional research found